Resources, Education & References for HPV Vaccine

Vaccine Recommendations

• Human Papillomavirus (HPV) ACIP Vaccine Recommendations
• CDC Recommends Only Two HPV Shots for Younger Adolescents
• MMWR: Use of 9-Valent Human Papillomavirus (HPV) Vaccine

 

HPV Vaccine

• Markowitz L, Dunne EF, Saraiya M, Curtis RC, Gee J, Bocchini JA, et al. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2014 Aug 29; 63(rr05):1-30.

HPV Vaccine Safety

• Langer-Gould A, Qian L, Tartof SY, et al. Vaccines and the Risk of Multiple Sclerosis and Other Central Nervous System Demyelinating Diseases. JAMA Neurol. 2014;71(12):1506-1513.
• Stokley S, Jeyarajah J, Yankey D, Cano M, Gee J, Roark J, et al. Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014 — United States. MMWR. 2014 Jul 25; 63(29):620-4.
• Grimaldi-Bensouda L, Guillemot D, Godeau B, Benichou J, Lebrun-Frenay C, Papeix C, et al. Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects. J Intern Med. 2014 Apr; 275(4):398-408.
• Macartney KK, Chiu C, Georgousakis M, Brotherton JM. Safety of human papillomavirus vaccines: a review. Drug Saf. 2013 Jun; 36(6):393-412.
• Klein NP, Hansen J, Chao C, Velicer C, Emery M, Slezak J, et al. Safety of quadrivalent human papillomavirus vaccine administered routinely to females. Arch Pediatr Adolesc Med. 2012 Dec; 166(12):1140-8.
• Gee J, Naleway A, Shui I, Baggs J, Yin R, Li R, et al. Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink. Vaccine. 2011 Oct 26; 29(46):8279-84.
• Markowitz LE, Hariri S, Unger ER, Saraiya M, Datta SD, Dunne EF. Post-licensure monitoring of HPV vaccine in the United States. Vaccine. 2010 Jul 5; 28(30):4731-7.
• Slade BA, Leidel L, Vellozzi C, Woo EJ, Hua W, Sutherland A, et al. Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA. 2009 Aug 19; 302(7):750-7.

HPV Vaccine Impact

• Chesson HW, Ekwueme DU, Saraiya M, Dunne EF, Markowitz LE. The estimated impact of human papillomavirus vaccine coverage on the lifetime cervical cancer burden among girls currently aged 12 years and younger in the United States. Sex Transm Dis. 2014 Nov; 41(11):656-9.
• Ferris D, Samakoses R, Block SL, Lazcano-Ponce E, Restrepo JA, Reisinger KS, et al. Long-term Study of a Quadrivalent Human Papillomavirus Vaccine [11 pages]. Pediatrics. 2014 Aug 18. [Epub ahead of print].
• Hariri S, Markowitz LE, Dunne EF, Unger ER. Population impact of HPV vaccines: summary of early evidence. J Adolesc Health. 2013 Dec; 53(6):679-82.
• Markowitz LE, Hariri S, Lin C, Dunne EF, Steinau M, McQuillan G, et al. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010. J Infect Dis. 2013 Aug 1; 208(3):385-93.
• Jemal A, Simard EP, Dorell C, Noone AM, Markowitz LE, Kohler B, et al. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst. 2013 Feb 6; 105(3):175-201.
• Powell SE, Hariri S, Steinau M, Bauer HM, Bennett NM, Bloch KC, et al. Impact of human papillomavirus (HPV) vaccination on HPV 16/18-related prevalence in precancerous cervical lesions. Vaccine. 2012 Dec 17; 31(1):109-13.
• Kahn JA, Brown DR, Ding L, Widdice LE, Shew ML, Glynn S, et al. Vaccine-type human papillomavirus and evidence of herd protection after vaccine introduction. Pediatrics. 2012 Aug; 130(2):e249-56.

HPV Vaccine and Sexual Behavior

• Bednarczyk RA, Davis R, Ault K, Orenstein W, Omer SB. Sexual activity-related outcomes after human papillomavirus vaccination of 11- to 12-year-olds. Pediatrics. 2012 Nov; 130(5):798-805.
• Forster AS, Marlow LA, Stephenson J, Wardle J, Waller J. Human papillomavirus vaccination and sexual behaviour: cross-sectional and longitudinal surveys conducted in England. Vaccine. 2012 Jul 13; 30(33):4939-44.
• Liddon NC, Leichliter JS, Markowitz LE. Human papillomavirus vaccine and sexual behavior among adolescent and young women. Am J Prev Med. 2012 Jan; 42(1):44-52.

HPV Vaccination of Males

• Allison MA, Dunne EF, Markowitz LE, O'Leary ST, Crane LA, Hurley LP, et al. HPV vaccination of boys in primary care practices. Acad Pediatr. 2013 Sep-Oct; 13(5):466-74.
• Chesson HW, Ekwueme DU, Saraiya M, Dunne EF, Markowitz LE. The cost-effectiveness of male HPV vaccination in the United States. Vaccine. 2011 Oct 26; 29(46):8443-50.

HPV Vaccination Coverage Issues

• Ng J, Ye F, Roth L, Sobel K, Byron S, Barton M, et al. Human papillomavirus vaccination series initiation and completion, 2008-2009. MMWR. 2015 Oct; 64(42):1185-9.
• Perkins RB, Clark JA, Apte G, Vercruysse JL, Sumner JJ, Wall-Haas CL, et al. Missed Opportunities for HPV Vaccination in Adolescent Girls: A Qualitative Study [11 pages]. Pediatrics. 2014 Aug 18. [Epub ahead of print].
• Noronha AS, Markowitz LE, Dunne EF. Systematic review of human papillomavirus vaccine coadministration. Vaccine. 2014 May 13; 32(23):2670-4.
• Dorell CG, Stokley S, Yankey D, Markowitz LE. Compliance with recommended dosing intervals for HPV vaccination among females, 13-17 years, National Immunization Survey-Teen, 2008-2009. Vaccine. 2012 Jan 11; 30(3):503-5.
• Dorell CG, Yankey D, Santibanez TA, Markowitz LE. Human papillomavirus vaccination series initiation and completion, 2008-2009. Pediatrics. 2011 Nov; 128(5):830-9.
• Widdice LE, Bernstein DI, Leonard AC, Marsolo KA, Kahn JA. Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 doses. Pediatrics. 2011 Jan; 127(1):77-84.
• Kilgore C. How to Meet the HPV Counseling And Vaccination Challenge. Pediatric News. 2011 Jan 1.
• Oster NV, McPhillips-Tangum CA, Averhoff F, Howell K. Barriers to adolescent immunization: a survey of family physicians and pediatricians. J Am Board Fam Pract. 2005 Jan-Feb; 18(1):13-9.

 Top of Page

Materials for Healthcare Professionals

• Pink Book Chapter on Human Papillomavirus
• Ask the Experts: HPV
• Traveler’s Health (Yellow Book) Chapter on Sexually Transmitted Diseases
• HPV Vaccine Information for Clinicians [4 pages]
• HPV Vaccination Coverage Data
• Addressing Parents’ Top Questions About HPV Vaccine [1 page]
• Top 10 Ways to Improve HPV Vaccination Rates in Your Practice [1 page]
• Speaking About HPV Vaccine to Your Colleagues
• HPV Vaccine Tools and Materials for Your Office
• Information for Health Care Professionals About Adolescent Vaccines [4 pages]
• Child and Adolescent Immunization Schedule

 

Provider Education

• Self-Study STD Curriculum Modules for Clinicians
• HPV in Our Midst: Understanding the Problem and Having the Conversation
• You Are The Key to HPV Cancer Prevention (CME/CE credit is available.)
• Recommending HPV Vaccine Successfully
• You Call the Shots: Web-Based Training Course

 

Resources for Patients

• HPV (Human Papillomavirus) Gardasil Vaccine Information Statement (VIS)
  In English | Other languages
• HPV (Human Papillomavirus) Gardasil-9 Vaccine Information Statement (VIS)
  In English | Other languages
• FAQs on HPV Vaccine
• HPV Vaccine Safety
• HPV Vaccine Fact Sheet [2 pages]
• HPV Vaccines: Vaccinating Your Preteen or Teen
• HPV Vaccine Information For Young Women
• What Parents Should Know About HPV Vaccine Safety and Effectiveness [1 page]
• Put Vaccination on Your Back-to-School List
• HPV and Cancer
• Pictures of HPV

Warning: Some of these photos are graphic.

• Basic Information About Cervical Cancer
• Vaccinate Your Preteen This Summer
• Infographic: 3 Things Parents Need to Know About Preventing Cancers
• HPV and Oropharyngeal Cancer - Fact Sheet

 

Other Resources

• Human Papillomavirus – Associated Cancers – United States, 2008-2012
• 4vHPV (Gardasil) Package Insert [28 pages]
• 9vHPV (Gardasil-9) Package Insert [23 pages]
• Archived HPV-Related Reports, Data & Statistics, and Presentations
• Incidence, Prevalence, and Cost of Sexually Transmitted Infections in the United States

Top of Page